Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SuVitas is an India-based healthcare company focused on inpatient transition care and rehabilitation, positioned between hospital discharge and home care. The company operates rehabilitation centers and related services for patients recovering from neurology, neurosurgery, orthopedics, cardiology, trauma, oncology, and age-related conditions. SuVitas emphasizes multidisciplinary, protocol-based recovery programs delivered in a home-like setting, and it has also developed an internal technology platform to capture quality-of-life data and manage care workflows. Originally launched as an independent startup, the business was acquired by HealthCare atHOME in 2021 and now operates as HCAH SuVitas. Its business is services-driven rather than drug-development oriented, with commercial operations in Indian rehabilitation and transition-care markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SuVitas.